Forte Biosciences Inc
Forte Biosciences Inc Stock, NASDAQ:FBRX
Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Torrance, CA.